Stay updated on Itolizumab in Lupus Nephritis Clinical Trial
Sign up to get notified when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.

Latest updates to the Itolizumab in Lupus Nephritis Clinical Trial page
- Check4 days agoChange DetectedBiocon Limited is listed as sponsor/collaborator in the study record, replacing Equillium. The record shows a new revision (v3.5.5) dated 2026-06-04, indicating an update to the sponsor/identification information.SummaryDifference0.8%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe Record History page shows a new revision label (v3.5.4) replacing the previous v3.5.3, indicating an updated release of the page’s revision history information.SummaryDifference0.1%

- Check40 days agoChange DetectedThe history now includes a newer Revision: v3.5.3. The older Revision: v3.5.2 is removed from the history view.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.5.2 to the history. Deleted Revision: v3.5.0 from the history.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page's revision history.SummaryDifference0.1%

- Check90 days agoChange DetectedAdded revision v3.4.3 to the study history and removed revision v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Itolizumab in Lupus Nephritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Itolizumab in Lupus Nephritis Clinical Trial page.